Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on year to $713.4 million. The company expects the full year’s revenue to be around $3.06 billion, close to analysts’ estimates. Its non-GAAP loss of $0.06 per share was 67.9% above analysts’ consensus estimates.
Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 15.6% year on year to $747.3 million. The company’s full-year revenue guidance of $3.15 billion at the midpoint came in 1.5% above analysts’ estimates. Its non-GAAP profit of $0.92 per share was 24.6% above analysts’ consensus estimates.
Higher education company Grand Canyon Education (NASDAQ:LOPE) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 5.1% year on year to $292.6 million. The company expects next quarter’s revenue to be around $287 million, coming in 0.5% above analysts’ estimates. Its GAAP profit of $2.84 per share was 1% below analysts’ consensus estimates.
Data analytics software provider Amplitude (NASDAQ:AMPL) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 9.4% year on year to $78.13 million. Guidance for next quarter’s revenue was optimistic at $79.5 million at the midpoint, 2.3% above analysts’ estimates. Its non-GAAP profit of $0.02 per share was in line with analysts’ consensus estimates.
Racing, gaming, and entertainment company Churchill Downs (NASDAQ:CHDN) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 11.2% year on year to $624.2 million. Its non-GAAP profit of $0.92 per share was 4.3% below analysts’ consensus estimates.
Staffing cuts at the FHA threaten to disrupt an agency that has historically insured more than 10% of the market.
The 2025 stock market rally has not been kind to short sellers.
Analog Devices shares soared to an all-time high Wednesday after the company’s fiscal first-quarter results topped expectations and the company boosted its share-buyback program.
Hims & Hers Health shares jumped some 20% to a record high on Wednesday following the announcement that it acquired lab testing facility Trybe Labs.
(Bloomberg) -- The global energy market needs trilateral discussions between Russia, the US and Saudi Arabia, said President Vladimir Putin.Most Read from BloombergTrump to Halt NY Congestion Pricing by Terminating ApprovalSorry, Kids: Disney’s New York Headquarters Is for Grown-UpsAirbnb Billionaire Offers Pre-Fab Homes for LA Fire VictimsChild Migrant Watchdog Gutted in DOGE CutsChicago Council Delays $830 Million Bond Vote Amid ScrutinyThe comments follow the meeting between top officials fro